{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:56Z","timestamp":1790726456352,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":239,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011542","name":"CCaTS","doi-asserted-by":"publisher","award":["UL1TR002377"],"award-info":[{"award-number":["UL1TR002377"]}],"id":[{"id":"10.13039\/100011542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.idcr.2026.e02746","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:50:35Z","timestamp":1788245435000},"page":"e02746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nontuberculous mycobacterial infections in the setting of immune checkpoint inhibitor therapy: A case series"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-8710","authenticated-orcid":false,"given":"Joelle N.","family":"Friesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Egan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.idcr.2026.e02746_bib1","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.idcr.2026.e02746_bib2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.idcr.2026.e02746_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.resinv.2024.02.002","article-title":"Cancer immunotherapy with immune checkpoint inhibitors and infections: a particular focus on mycobacterial infections","volume":"62","author":"Fujita","year":"2024","journal-title":"Respir Investig"},{"key":"10.1016\/j.idcr.2026.e02746_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rmed.2018.11.021","article-title":"Emerging concerns of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy","volume":"146","author":"Fujita","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.idcr.2026.e02746_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejca.2020.09.025","article-title":"Infectious complications in patients treated with immune checkpoint inhibitors","volume":"141","author":"Karam","year":"2020","journal-title":"Eur J Cancer"},{"issue":"23","key":"10.1016\/j.idcr.2026.e02746_bib6","doi-asserted-by":"crossref","first-page":"9027","DOI":"10.1002\/cam4.3532","article-title":"Characteristics and risk factors for microbial infections during cancer immune checkpoint therapy","volume":"9","author":"Kanjanapan","year":"2020","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.idcr.2026.e02746_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13303","article-title":"Incidence and predictors of infections in patients with advanced non-small cell lung cancer treated with checkpoint inhibitor immunotherapies: a monocentric retrospective cohort study","volume":"98","author":"Bavaro","year":"2023","journal-title":"Scand J Immunol"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02746_bib8","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1093\/oncolo\/oyad340","article-title":"Increased tuberculosis reactivation risk in patients receiving immune checkpoint inhibitor-based therapy","volume":"29","author":"Chen","year":"2024","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02746_bib9","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/S1470-2045(19)30674-6","article-title":"Immune checkpoint inhibitors and tuberculosis: an old disease in a new context","volume":"21","author":"Langan","year":"2020","journal-title":"Lancet Oncol"},{"issue":"30","key":"10.1016\/j.idcr.2026.e02746_bib10","doi-asserted-by":"crossref","first-page":"13402","DOI":"10.1073\/pnas.1007394107","article-title":"Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis","volume":"107","author":"L\u00e1z\u00e1r-Moln\u00e1r","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02746_bib11","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.21037\/jtd-23-1395","article-title":"A narrative review of the controversy on the risk of mycobacterial infections with immune checkpoint inhibitor use: does Goldilocks have the answer?","volume":"16","author":"Vaddi","year":"2024","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.idcr.2026.e02746_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1047781","article-title":"Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease","volume":"13","author":"Ratnatunga","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02746_bib13","doi-asserted-by":"crossref","first-page":"00364-2022","DOI":"10.1183\/23120541.00364-2022","article-title":"Nontuberculous mycobacterial infections during cancer therapy with immune checkpoint inhibitors: a systematic review","volume":"8","author":"Lombardi","year":"2022","journal-title":"ERJ Open Res"},{"issue":"55","key":"10.1016\/j.idcr.2026.e02746_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf3861","article-title":"PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques","volume":"6","author":"Kauffman","year":"2021","journal-title":"Sci Immunol"},{"issue":"11","key":"10.1016\/j.idcr.2026.e02746_bib15","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/cid\/ciw539","article-title":"The spectrum of serious infections among patients receiving immune checkpoint blockade for the treatment of melanoma","volume":"63","author":"Del Castillo","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02746_bib16","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.cmi.2018.01.030","volume":"24","author":"Redelman-Sidi","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02746_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s40425-019-0645-6","article-title":"Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance","volume":"7","author":"Couey","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02746_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.21.02229","article-title":"Long-term outcomes with nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanoma","volume":"40","author":"Wolchok","year":"2022","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.idcr.2026.e02746_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3892\/mco.2022.2537","article-title":"Transition of the PD-1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re-challenge","volume":"16","author":"Nose","year":"2022","journal-title":"Mol Clin Oncol"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926002593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926002593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:14:35Z","timestamp":1790723675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250926002593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":19,"alternative-id":["S2214250926002593"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02746","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nontuberculous mycobacterial infections in the setting of immune checkpoint inhibitor therapy: A case series","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02746","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02746"}}